Clinical review: Vasculitis on the intensive care unit - Part 2: Treatment and prognosis

Critical Care

Volumn 9, Issue 2, 2005, Pages 193-197

  Semple, David ^a   Keogh, James ^a   Forni, Luigi ^a   Venn, Richard ^a  

^a WORTHING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALPHA INTERFERON; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPERTENSIVE AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; INSULIN; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISOLONE; T LYMPHOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY; VITAMIN D;

ACUTE KIDNEY FAILURE; AMENORRHEA; BLADDER CARCINOMA; CHURG STRAUSS SYNDROME; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; DEEP VEIN THROMBOSIS; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FEMALE INFERTILITY; GASTROINTESTINAL HEMORRHAGE; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTENSIVE CARE UNIT; LUNG HEMORRHAGE; LYMPHOMA; MAINTENANCE THERAPY; MICROSCOPIC POLYANGIITIS; MORBIDITY; MORTALITY; MYELODYSPLASIA; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RESPIRATORY TRACT DISEASE; REVIEW; SEPSIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UPPER RESPIRATORY TRACT OBSTRUCTION; VASCULITIS; WEGENER GRANULOMATOSIS;

ADRENAL CORTEX HORMONES; CHURG-STRAUSS SYNDROME; CRITICAL CARE; CYCLOPHOSPHAMIDE; HEPATITIS B; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; MULTICENTER STUDIES; PLASMA EXCHANGE; POLYARTERITIS NODOSA; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTORS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 15844390730     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2937     Document Type: Review

References (41)

1. Griffith M, Brett S: The pulmonary physician in critical care - illustrative case 3: pulmonary vasculitis. Thorax 2003, 58:543-546
2. Fauci AS, Katz P, Haynes BF, Wolff SM: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 1979, 301:235-238.
3. Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003, 63: 670-677.
4. Nachman PH, Hogan SL, Jennette JC, Falk RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996, 7:33-39.
5. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
6. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001, 44:666-675.
7. Clutterbuck EJ, Evans DJ, Pusey CD: Renal involvement in Churg-Strauss syndrome. Nephrol Dial Transplant 1990, 5: 161-167.
8. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B: Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss anglitis: a study in 165 patients. Br J Rheumatol 1988, 27: 58-264.
9. Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, et al.: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997, 40:2187-2198.
10. de Groot K, Adu D, Savage CO: The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001, 16: 018-2027.
11. Conron M, Beynon HL: Churg-Strauss syndrome. Thorax 2000, 55:870-877.
12. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, et al.: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349:36-44.
13. Guillevin L, Cohen P, Mahr A, Arene JP, Mouthon L, Puechal X, Pertuiset E, Gilson B, Hamidou M, Lanoux P, et al.: Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003, 49:93-100.
14. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991, 40:757-763.
15. Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, Clark W, Morrin P, Posen G, Bernstein K, et al.: A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis 1992, 20:261-269.
16. Guillevin L, Cevallos R, Durand-Gasselin B, Lhote F, Jarrousse B, Callard P: Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, Meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis. Ann Med Interne (Paris) 1997, 148: 98-204.
17. Gallagher H, Kwan JT, Jayne DR: Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002, 39: 42-47.
18. Gaskin G, Jayne DR, European Vasculitis Study Group: Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. In The Renal Association: 9-11 October 2002; London. London: The Renal Association; 2002:8.
19. Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Genereau T, Leon A, Bussel A: Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995, 38: 1638-1645.
20. Guillevin L, Lhote F, Jarrousse B, Bironne P, Barrier J, Deny P, Trepo C, Kahn MF, Godeau P: Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Med Interne (Paris) 1992, Suppl 1:63-74.
21. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, Noel LH, Trepo C: Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995, 74:238-253.
22. Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, Imbert B, Hausfater P, Roudier J, Bielefeld P, et al.: Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004, 51:482-487.
23. Erhardt A, Sagir A, Guillevin L, Neuen-Jacob E, Haussinger D: Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. J Hepatol 2000, 33:677-683.
24. Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C: Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol 1993, 20:289-298.
25. Guillevin L, Lhote F, Sauvaget F, Deblois P, Rossi F, Levallois D, Pourrat J, Christoforov B, Trepo C: Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994, 53:334-337.
26. Wicki J, Olivieri J, Pizzolato G, Sarasin F, Guillevin L, Dayer JM, Chizzolini C: Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Rheumatology (Oxford) 1999, 38:183-185.
27. Hamilos DL, Christensen J: Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. J Allergy Clin Immunol 1991, 88:823-824.
28. Tsurikisawa N, Taniguchi M, Saito H, Himeno H, Ishibashi A, Suzuki S, Akiyama K: Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol 2004, 92:80-87.
29. Reid IR, Heap SW: Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990, 150:2545-2548.
30. Gluth MB, Shinners PA, Kasperbauer JL: Subglottic stenosis associated with Wegener's granulomatosis. Laryngoscope 2003, 113:1304-1307.
31. Langford CA, Sneller MC, Hallahan CW, Hoffman GS, Kammerer WA, Talar-Williams C, Fauci AS, Lebovics RS: Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Arthritis Rheum 1996, 39:1754-1760.
32. Moloney ED, Griffiths MJ: Protective ventilation of patients with acute respiratory distress syndrome. Br J Anaesth 2004, 92: 261-270.
33. Soding PF, Lockwood CM, Park GR: The intensive care of patients with fulminant vasculitis. Anaesth Intensive Care 1994, 22:81-89.
34. Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, Hoang P, Guillevin L: Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford) 2003, 42:1183-1188.
35. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
36. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
37. Matteson EL, Gold KN, Bloch DA, Hunder GG: Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med 1996, 101:129-134.
38. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P: Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17-28.
39. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. OJM 1994, 87:67-678.
40. Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S: Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000, 15: 11-618.
41. Guillevin L, Jarrousse B, Lok C, Lhote F, Jais JP, Le Thi Huong Du D, Bussel A: Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol 1991, 18: 67-574.